Genomic analysis offers roadmap for diagnosis and treatment of a highrisk leukaemia

Genomic analysis offers roadmap for diagnosis and treatment of a high-risk leukaemia

Acute erythroid leukaemia (AEL) is a high-risk cancer with a dismal prognosis, uncertain genetic basis and controversy surrounding the diagnosis. That is changing, thanks to research led by St. Jude Children's Research Hospital that appears in the...

More From BioPortfolio on "Genomic analysis offers roadmap for diagnosis and treatment of a high-risk leukaemia"